Taiwan · Delayed Price · Currency is TWD TSH Biopharm Corporation Statistics
Total Valuation
TPEX:8432 has a market cap or net worth of TWD 1.95 billion. The enterprise value is 1.32 billion.
| Market Cap | 1.95B |
| Enterprise Value | 1.32B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 38.40M |
| Shares Outstanding | 38.40M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 0.72% |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 14.06.
| PE Ratio | 14.06 |
| Forward PE | n/a |
| PS Ratio | 1.46 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | 14.48 |
| P/OCF Ratio | 14.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.40, with an EV/FCF ratio of 9.75.
| EV / Earnings | 9.45 |
| EV / Sales | 0.98 |
| EV / EBITDA | 5.40 |
| EV / EBIT | 6.03 |
| EV / FCF | 9.75 |
Financial Position
The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.27 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.14 |
| Interest Coverage | 273.99 |
Financial Efficiency
Return on equity (ROE) is 11.24% and return on invested capital (ROIC) is 21.70%.
| Return on Equity (ROE) | 11.24% |
| Return on Assets (ROA) | 7.20% |
| Return on Invested Capital (ROIC) | 21.70% |
| Return on Capital Employed (ROCE) | 12.66% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | 17.59M |
| Profits Per Employee | 1.83M |
| Employee Count | 76 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 3.95 |
Taxes
In the past 12 months, TPEX:8432 has paid 46.97 million in taxes.
| Income Tax | 46.97M |
| Effective Tax Rate | 20.00% |
Stock Price Statistics
The stock price has decreased by -10.54% in the last 52 weeks. The beta is 0.34, so TPEX:8432's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -10.54% |
| 50-Day Moving Average | 54.46 |
| 200-Day Moving Average | 52.45 |
| Relative Strength Index (RSI) | 27.00 |
| Average Volume (20 Days) | 37,016 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:8432 had revenue of TWD 1.34 billion and earned 139.26 million in profits. Earnings per share was 3.62.
| Revenue | 1.34B |
| Gross Profit | 680.74M |
| Operating Income | 218.37M |
| Pretax Income | 234.79M |
| Net Income | 139.26M |
| EBITDA | 231.38M |
| EBIT | 218.37M |
| Earnings Per Share (EPS) | 3.62 |
Balance Sheet
The company has 932.28 million in cash and 18.64 million in debt, with a net cash position of 913.64 million or 23.79 per share.
| Cash & Cash Equivalents | 932.28M |
| Total Debt | 18.64M |
| Net Cash | 913.64M |
| Net Cash Per Share | 23.79 |
| Equity (Book Value) | 1.72B |
| Book Value Per Share | 37.57 |
| Working Capital | 1.20B |
Cash Flow
In the last 12 months, operating cash flow was 139.52 million and capital expenditures -4.52 million, giving a free cash flow of 135.00 million.
| Operating Cash Flow | 139.52M |
| Capital Expenditures | -4.52M |
| Depreciation & Amortization | 13.01M |
| Net Borrowing | -12.24M |
| Free Cash Flow | 135.00M |
| FCF Per Share | 3.52 |
Margins
Gross margin is 50.93%, with operating and profit margins of 16.34% and 10.42%.
| Gross Margin | 50.93% |
| Operating Margin | 16.34% |
| Pretax Margin | 17.57% |
| Profit Margin | 10.42% |
| EBITDA Margin | 17.31% |
| EBIT Margin | 16.34% |
| FCF Margin | 10.10% |
Dividends & Yields
This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 5.10%.
| Dividend Per Share | 2.61 |
| Dividend Yield | 5.10% |
| Dividend Growth (YoY) | 65.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 58.45% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 5.05% |
| Earnings Yield | 7.13% |
| FCF Yield | 6.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
TPEX:8432 has an Altman Z-Score of 7.42 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.42 |
| Piotroski F-Score | 6 |